The new administration's freeze on foreign aid (affecting America's sweeping anti-HIV initiative PEPFAR) has raised concerns ...

A series of orders from the Trump administration have the potential to disrupt the delivery of life-saving medications to HIV ...

Pseudoscience has recently been reemerging in the US. While much of it concerns vaccines, an "oldie" is again making the ...

If left untreated, human immunodeficiency virus (HIV) almost always will progress to AIDS, even after many years. The immune defenses become compromised and the body is less able to defend itself ...

A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Regensburg has unveiled insights into how HIV-1, the virus responsible ...

Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy. The litigation ...

While the DeFi boom of 2020 catalyzed the broader blockchain ecosystem, this cycle may take a more evolved and measured approach, emphasizing utility and long-term sustainability. DeFi has ...

If you're worried about HIV infection, you may wonder whether it's safe to have oral sex. While it's not risk-free, the chances of spreading the virus that causes AIDS are very low if you take the ...

Many of the fears have been fueled by media reports which either overstate the risk of acquiring HIV through accidental occupational needlestick injuries or spotlight cases in which victims are ...

Galway nurse Aoife Commins believes that as a white, heterosexual woman who is knowledgeable about sexual health, she is an example of how becoming HIV-positive can happen to anyone. She was ...

Mesoblast shares fall ~7% after a $260 million placement following FDA approval for its cell therapy treatment remestemcel-L in December Atomo Diagnostics inks a five-year $5.44 million deal with ...